newsfilter
← Latest News
ACCESS Newswire·

Sanofi To Acquire Kadmon To Further Strengthen Growth of Transplant Business

Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy PARIS, FRANCE and N